Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
1.160
+0.020 (1.75%)
Apr 2, 2026, 2:27 PM HKT
HKG:2348 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,166 | 1,158 | 905.83 | 811.68 | 577.74 |
Short-Term Investments | - | 242.34 | 107 | 88.8 | 44.3 |
Trading Asset Securities | 410.49 | 207.14 | 160.87 | 181.36 | 208.18 |
Cash & Short-Term Investments | 1,577 | 1,608 | 1,174 | 1,082 | 830.22 |
Cash Growth | -1.92% | 36.98% | 8.49% | 30.31% | -13.71% |
Accounts Receivable | 265.22 | 267.89 | 322 | 402.85 | 346.78 |
Other Receivables | - | - | - | - | 20.8 |
Receivables | 265.22 | 267.89 | 322 | 402.85 | 367.58 |
Inventory | 215.44 | 308.24 | 211.11 | 241.75 | 203.48 |
Prepaid Expenses | 236.04 | 7.38 | 13.4 | 14.99 | 15.5 |
Other Current Assets | - | 11 | - | 2.58 | 94.26 |
Total Current Assets | 2,294 | 2,202 | 1,720 | 1,744 | 1,511 |
Property, Plant & Equipment | 1,174 | 1,228 | 1,217 | 1,301 | 1,143 |
Long-Term Investments | 20 | 20 | 20 | 25.35 | 87.25 |
Goodwill | 241.16 | 241.16 | 241.16 | 241.16 | 241.16 |
Other Intangible Assets | 272.07 | 164.77 | 160.31 | 109.48 | 97.99 |
Long-Term Deferred Tax Assets | 4.91 | 5.47 | 18.98 | 6.86 | 5.75 |
Long-Term Deferred Charges | - | 136.16 | 128 | 185.54 | 189.03 |
Other Long-Term Assets | 3.57 | 11.08 | 10.3 | 7.56 | 14.36 |
Total Assets | 4,009 | 4,009 | 3,623 | 3,673 | 3,340 |
Accounts Payable | 173.78 | 221.56 | 162.16 | 224.07 | 143.21 |
Accrued Expenses | - | 99.34 | 108.27 | 171.28 | 156.94 |
Short-Term Debt | 77.48 | 29.86 | 120.06 | 6.43 | 21.01 |
Current Portion of Leases | - | 1.16 | 0.36 | 1.53 | 0.98 |
Current Income Taxes Payable | 6.48 | 2.6 | 45.23 | 8.65 | 15.5 |
Current Unearned Revenue | - | 32.73 | 17.9 | 29.66 | 14.45 |
Other Current Liabilities | 236.24 | 167.35 | 214.96 | 490.43 | 345.01 |
Total Current Liabilities | 493.97 | 554.6 | 668.94 | 932.06 | 697.1 |
Long-Term Leases | - | 3.7 | 0.1 | 0.44 | 1.53 |
Long-Term Unearned Revenue | 2.88 | 3.36 | - | 0.3 | 0.6 |
Long-Term Deferred Tax Liabilities | 127.51 | 120.95 | 94.38 | 89.98 | 66.87 |
Other Long-Term Liabilities | - | - | - | - | 175.6 |
Total Liabilities | 624.36 | 682.61 | 763.43 | 1,023 | 941.7 |
Common Stock | 80.6 | 80.53 | 80.46 | 80.39 | 80.37 |
Additional Paid-In Capital | - | 105.95 | 104.41 | 103.09 | 102.7 |
Retained Earnings | - | 3,102 | 2,649 | 2,436 | 2,174 |
Comprehensive Income & Other | 3,304 | 35.5 | 21.24 | 22.51 | 23.2 |
Total Common Equity | 3,385 | 3,324 | 2,855 | 2,642 | 2,381 |
Minority Interest | - | 2.4 | 4.58 | 7.91 | 17.15 |
Shareholders' Equity | 3,385 | 3,327 | 2,859 | 2,650 | 2,398 |
Total Liabilities & Equity | 4,009 | 4,009 | 3,623 | 3,673 | 3,340 |
Total Debt | 77.48 | 34.72 | 120.53 | 8.41 | 23.52 |
Net Cash (Debt) | 1,499 | 1,573 | 1,053 | 1,073 | 806.7 |
Net Cash Growth | -4.68% | 49.36% | -1.89% | 33.06% | -15.90% |
Net Cash Per Share | 1.00 | 1.04 | 0.70 | 0.71 | 0.53 |
Filing Date Shares Outstanding | 1,503 | 1,502 | 1,500 | 1,499 | 1,498 |
Total Common Shares Outstanding | 1,503 | 1,502 | 1,500 | 1,499 | 1,498 |
Working Capital | 1,800 | 1,648 | 1,051 | 811.94 | 813.93 |
Book Value Per Share | 2.25 | 2.21 | 1.90 | 1.76 | 1.59 |
Tangible Book Value | 2,872 | 2,918 | 2,453 | 2,291 | 2,042 |
Tangible Book Value Per Share | 1.91 | 1.94 | 1.64 | 1.53 | 1.36 |
Buildings | - | 788.38 | 584.74 | 531.28 | 243.42 |
Machinery | - | 634.79 | 485.74 | 721.4 | 624.16 |
Construction In Progress | - | 85.57 | 356.9 | 495.14 | 675.2 |
Leasehold Improvements | - | 6.68 | 6.66 | 6.64 | 6.59 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.